These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 11129289

  • 1. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination therapy with SCH58500 (p53 adenovirus) and cyclophosphamide in preclinical cancer models.
    Nielsen LL.
    Oncol Rep; 2000 Nov; 7(6):1191-6. PubMed ID: 11032912
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
    Boulay JL, Perruchoud AP, Reuter J, Bolliger C, Herrmann R, Rochlitz C.
    Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L, Mills GB, Burke TW, Wolf JK.
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO, Gómez-Navarro J, Xiang J, Barnes MN, Mahasreshti P, Alvarez RD, Siegal GP, Badib AO, Buchsbaum D, Curiel DT, Stackhouse MA.
    Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL.
    Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
    [Abstract] [Full Text] [Related]

  • 13. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 14. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
    Ikeguchi M, Nakamura S, Kaibara N.
    Oncol Rep; 2002 Mar; 9(5):1121-6. PubMed ID: 12168083
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL, Russell PJ, Knittel T, Milross C.
    Prostate; 2007 Nov 01; 67(15):1630-40. PubMed ID: 17823933
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K, Li Z, Seth P, Cowan KH, Sinha BK.
    Oncol Res; 1997 Nov 01; 9(11-12):603-9. PubMed ID: 9563008
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y, Gilbert JD, Kim JH, Freytag SO.
    Clin Cancer Res; 1999 Dec 01; 5(12):4224-32. PubMed ID: 10632364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.